Various factors that influence HCV disease progression including steatosis, obesity, insulin resistance, diabetes, race/ethnicity, and general studies on disease progression

AASLD: Higher Caffeine Consumption is associated with Milder Fibrosis in patients with Chronic Liver Diseases

MAINTENANCE THERAPY FOUND INEFFECTIVE HALT-C STUDY

Clinical Relevance of Rapid Virological Response (RVR) in Decompensated HCV-Related Cirrhosis Treated With Peginterferon and Ribavirin

Long-term, Low-Dose Treatment with Pegylated Interferon Alfa-2b (PegIntron) Monotherapy Leads to a Reduction in Fibrosis and Inflammatory Scores in Prior Non-responders

What is the best non invasive method for early prediction of cirrhosis in chronic hepatitis C? Prospective comparison between Fibroscan and serum markers (Lok index, APRI, AST/ALT ratio, platelet count and Fibrotest) -

Long-Term, Low-Dose Treatment With Pegylated Interferon alfa-2b Leads to a Significant Reduction in Fibrosis and Inflammatory Scores in Chronic Hepatitis C Nonresponder Patients With Fibrosis or Cirrhosis

Treatment of Hepatitis C Patients with Child A and B cirrhosis with Consensus Interferon and Ribavirin in a Low Ascending Dosing Regimen Leads to Significant Viral Elimination Rates

MRI Predicts Liver Fibrosis, Study Says

HCV Advocate’s AASLD Conference coverage

Oct-Sept-June

Marianne Faithfull Has Hepatitis C -

Insulin Resistance Predicts Liver Fibrosis in Patients with Hepatitis C or Non-alcoholic Fatty Liver Disease

Ultrasound-Based Transient Elastography for the Detection of Hepatic Fibrosis: Systematic Review and Meta-analysis -

Stiffness and Impedance: The New Liver Biomarkers Editorial

Noninvasive Diagnosis of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Splenic Doppler Impedance Index -

Assessment of Hepatic Fibrosis With Magnetic Resonance Elastography -

Factors Associated with Long-term Liver Complications after Spontaneous HCV Clearance or Successful Treatment

CAD Increases Accuracy Of Diagnosing Liver Fibrosis

Natural History of Hepatitis C in Patients with Severe Liver Fibrosis

Stanford researchers develop new genetic marker test to predict likelyhood for progression to cirrhosis of hcv patients:

Liver Fibrosis Is Associated with Decreased Peripheral Platelet Count in Patient

Interesting link of Ablation of 'inoperable' Liver Tumors.

Ursodeoxycholic Acid May Reduce Liver Inflammation in Patients with Chronic Hepatitis C

FIB-4: An Inexpensive and Accurate Marker of Liver Fibrosis in Patients with Hepatitis C

Non-Invasive and Inexpensive Fibrosis Evaluation for HCV

The Pros and Cons of Using Marijuana with Hepatitis C

Comparison of 6 Non-invasive Measures for Diagnosing Liver Fibrosis in Hepatitis C Patients

Reversibility of hepatic fibrosis and cirrhosis-is it all hype? Editorial

Glucose Intolerance Associated with Advancing Liver Disease (Fibrosis)

Milk Thistle (Silymarin) Demonstrates Anti-inflammatory and Anti-HCV Activity in a Laboratory Study

A Follow-up Week 12 Viral Count Is Useful in Predicting SVR and Is 100% Accurate in Patients without Cirrhosis

MAY

Statins May Improve Liver Fibrosis -

The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in
chronic hepatitis C.

Response to PegIntron/ribavirin Leads to Stabilization of Fibrosis in Liver Transplant Recipients

Celera Publishes Data Validating Cirrhosis Risk Score As a Predictor of Cirrhosis in Chronic Hepatitis C Patients

April-March

Stem Cells Speed Growth Of Healthy Liver Tissue

Schering's Experimental Oral HCV Protease Inhibitor Boceprevir Appears Safe in Patients with Varying Degrees of Liver Impairment -

Researchers Identify Critical Receptor In Liver Regeneration

Interferon Gamma Does Not Reverse Fibrosis in Hepatitis C Patients with Advanced Liver Disease

Heavy Alcohol Use Worsens Disease Progression in Women with Chronic Hepatitis C

February

Liver Stiffness Measurement Versus Clinicians' Prediction or Both for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C -

Are Noninvasive Liver Fibrosis Tests Ready for Use? There are lots of questions. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C

New Index for Assessing Liver Fibrosis

Risk Factors for Liver Fibrosis in Veterans with Chronic Hepatitis

Noninvasive Markers of Liver Fibrosis

Efficacy of Low-dose versus Standard Dose Pegylated Interferon Alfa-2b (PegIntron) plus Ribavirin for Treatment of Chronic Hepatitis C with Severe Fibrosis

January

Treatment of Hepatitis C in Patients with Advanced Fibrosis or Cirrhosis

Iron Accumulation Gene Mutations and Liver Fibrosis in Patients with Hepatitis C

Impact of Disease Severity on HCV Treatment Outcomes in HALT-C Trial

News Archives

2008

2006

2005-2003